Income Statement

ENCOMPASS HEALTH CORP

EHC
Annual
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY Dec 31, 2018 2018 FY Dec 31, 2017 2017 FY Dec 31, 2016 2016 FY Dec 31, 2015 2015 FY Dec 31, 2014 2014 FY Dec 31, 2013 2013 FY Dec 31, 2012 2012 FY Dec 31, 2011 2011 FY Dec 31, 2010 2010 FY
Revenue
5,935.20 5,373.20 4,801.20 4,348.60 5,121.60 4,644.40 4,605.00 4,277.30 - - - - - - - -
Cost of Revenue
- - - - - - - - - - - - - - - -
Gross Profit
5,935.20 5,373.20 4,801.20 4,348.60 5,121.60 4,644.40 4,605.00 4,277.30 - - - - - - - -
Operating Expenses
236.20 209.20 201.70 154.30 197.30 155.50 247.00 220.20 171.70 133.40 133.30 124.80 119.10 117.90 110.50 106.20
Research & Development
- - - - - - - - - - - - - - - -
Selling, General & Administrative
236.20 209.20 201.70 154.30 197.30 155.50 247.00 220.20 171.70 133.40 133.30 124.80 119.10 117.90 110.50 106.20
Other Operating Expenses
- - - - - - - - - - - - - - - -
Operating Income
5,699.00 5,164.00 4,599.50 4,194.30 4,924.30 4,488.90 4,358.00 4,057.10 -171.70 -133.40 -133.30 -124.80 -119.10 -117.90 -110.50 -106.20
Non-Operating Income
4,746.00 4,414.40 3,992.30 3,743.50 4,267.10 4,016.30 3,795.70 4,587.90 -668.10 -615.40 -558.60 -550.30 -514.30 -475.30 -431.10 -
Interest Income
- - - - - - - - - - - - - - - -
Interest Expense
- - 143.50 175.70 164.60 184.20 159.70 147.30 154.40 172.10 - - - - - -
Other Non-Op Income / Expense
18.80 20.10 15.70 -5.20 12.30 10.60 32.30 22.40 21.70 19.60 13.60 31.20 4.50 8.50 3.50 4.60
Income Before Tax
953.00 749.60 607.20 450.80 657.20 472.60 562.30 509.70 496.40 482.00 425.30 425.50 395.20 357.40 320.60 -
Income Tax Expense
386.80 293.90 255.20 179.80 245.00 188.40 203.60 -823.10 240.10 234.40 242.20 203.50 71.60 172.40 111.90 -736.60
Non-Controlling Interest
192.90 148.20 111.00 94.90 105.00 84.60 87.10 83.10 79.10 70.50 69.70 59.70 57.80 50.90 45.90 40.80
Net Income
566.20 455.70 352.00 271.00 412.20 284.20 358.70 292.30 256.30 247.60 183.10 222.00 323.60 185.00 208.70 899.00
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY Dec 31, 2018 2018 FY Dec 31, 2017 2017 FY Dec 31, 2016 2016 FY Dec 31, 2015 2015 FY Dec 31, 2014 2014 FY Dec 31, 2013 2013 FY Dec 31, 2012 2012 FY Dec 31, 2011 2011 FY Dec 31, 2010 2010 FY
Depreciation & Amortization
- - - - - - - - - - - - - - - -
EBITDA
6,026.90 5,463.60 4,873.40 4,437.90 5,180.90 4,731.90 4,576.70 4,256.80 12.10 39.20 6.40 -17.10 -24.40 -35.40 -31.70 -29.80
Earnings Per Share (Basic)
5.62 4.53 3.51 2.72 4.15 2.87 3.65 2.98 2.73 2.77 2.02 2.46 2.58 1.69 1.96 9.41
Diluted EPS
5.54 4.46 3.47 2.70 4.11 2.85 3.61 2.93 2.69 2.59 1.91 2.29 2.58 1.69 1.96 8.28
Weighted Average Shares
100.50 99.90 99.50 99.20 99.00 98.60 98.00 97.90 93.70 89.10 89.40 86.80 88.10 94.60 93.30 92.80
Diluted Weighted Avg Shares
102.20 102.20 101.30 100.40 100.20 99.80 99.40 99.80 99.30 99.50 101.00 100.70 102.10 108.10 109.20 108.50
Comprehensive Income
566.70 455.70 352.00 271.00 412.20 284.20 402.00 373.30 274.50 275.90 255.60 277.50 322.10 215.80 208.00 899.50